Malte - anglais - Malta Medicines Authority

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - varicella virus, oka strain, live, attenuated, measles virus, schwarz strain, mumps virus, jeryl lynn, level b, rubella virus, wistar ra - powder and solvent for solution for injection in pre-filled syringe - varicella virus oka strain (live, attenuated) measles virus - schwarz strain mumps virus jeryl lynn (level b) strain (live, attenuated) rubella virus wistar ra 27/3 strain (live, attenuated) - vaccines

Malte - anglais - Malta Medicines Authority

glaxosmithkline biologicals s.a. rue de l'institut 89 b-1330 rixensart, belgium - varicella virus, oka strain, live, attenuated - powder and solvent for solution for injection - varicella virus oka strain (live, attenuated) 10 pfu/dose - vaccines

Malte - anglais - Malta Medicines Authority

merck sharp & dohme limited - varicella virus oka/merck strain (live, attenuated) - powder and solvent for suspension for injection - varicella virus oka/merck strain (live, attenuated) - vaccines

Philippines - anglais - FDA (Food And Drug Administration)

n/a; importer: zuellig pharma corporation; distributor: zuellig pharma corporation - japanese encephalitis virus (live, attenuated) - powder for suspension for injection (sc) - formulation: after reconstitution, one dose (0.5 ml) contains 4.0-5.8 log plaque forming units (pfu) live, attenuated, recombinant japanese encephalitis virus.

Philippines - anglais - FDA (Food And Drug Administration)

n/a; importer: zuellig pharma corporation; distributor: zuellig pharma corporation - japanese encephalitis vaccine (live, attenuated) - powder for suspension for injection (sc) - formulation: after reconstitution, one dose (0.5 ml) contains 4.0-5.8 log plaque forming units (pfu) live, attenuated, recombinant japanese encephalitis virus.

Philippines - anglais - FDA (Food And Drug Administration)

euro pharma inc - live attenuated trivalent oral polio vaccine - solution (drops) - 0.1ml

Philippines - anglais - FDA (Food And Drug Administration)

n/a; importer: merck sharp & dohme (i.a.) llc; distributor: merck sharp & dohme (i.a.) llc - measles, mumps and rubella vaccine (live, attenuated) - lyophilized powder for solution for injection (im/sc) - remarks: formulation: after reconstitution, each dose (0.5 ml) contains: live, attenuated virus derived from edmonston b strain of measles………………… 3.0 log tcid50* live, attenuated jeryl lynn strain of mumps…………..4.1 log tcid50* live, attenuated wistar ra27/3 strain of rubella. …………3.0 log tcid50* *tcid 50 - tissue culture infectivity dose 50%

Philippines - anglais - FDA (Food And Drug Administration)

glaxosmithkline philippines, inc. - measles, mumps, rubella (mmr) vaccine (live, attenuated) [see formulation on reverse side] - powder for solution for injection (sc) - after reconstitution, each dose (0.5ml) contains: measles virus (schwarz strain), live attenuated nlt 10 3.0 ccid 50 mumps vir

Irlande - anglais - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - varicella virus (oka strain) live attenuated - powder and solvent for suspension for injection - =1350 plaque forming unit - varicella, live attenuated

Union européenne - anglais - EMA (European Medicines Agency)

medimmune llc - reassortant influenza virus (live attenuated) of the following strains:a/california/7/2009 (h1n1)pdm09 like strain, a/victoria/361/2011 (h3n2) like strain, b/massachusetts/2/2012 like strain - influenza, human; immunization - vaccines - prophylaxis of influenza in individuals 24 months to less than 18 years of age.the use of fluenz should be based on official recommendations.